[ALNY] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
02-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 13.96%
YoY- -28.82%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 213,259 177,566 99,476 33,294 21,899 18,960 7,345 75.27%
PBT -239,356 -199,275 -181,646 -181,220 -141,276 -107,290 -102,974 15.08%
Tax 985 1,016 575 695 -62 -2,128 -6,414 -
NP -240,341 -200,291 -182,221 -181,915 -141,214 -107,290 -102,974 15.16%
Tax Rate - - - - - - - -
Total Cost 453,600 377,857 281,697 215,209 163,113 126,250 110,319 26.55%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -112.70 -112.80 -183.18 -546.39 -644.84 -565.88 -1,401.96 -34.29%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -2.00 -1.71 -1.62 -1.73 -1.41 -1.25 -1.21 8.73%
EPS Diluted -2.00 -1.71 -1.62 -1.73 -1.41 -1.25 -1.21 8.73%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.